USD
+$0.00
(+0.00%
)At Close (As of Sep 12, 2025)
$4.38M
Market Cap
-
P/E Ratio
-2441.21
EPS
$3,576.00
52 Week High
$4.22
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$36K |
Total Revenue | $0 |
Cost Of Revenue | $36K |
Costof Goods And Services Sold | $36K |
Operating Income | -$15M |
Selling General And Administrative | $4.7M |
Research And Development | $9.5M |
Operating Expenses | $15M |
Investment Income Net | - |
Net Interest Income | -$566K |
Interest Income | $62K |
Interest Expense | $583K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $36K |
Income Before Tax | $23M |
Income Tax Expense | $23M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$23M |
Comprehensive Income Net Of Tax | - |
Ebit | -$22M |
Ebitda | -$22M |
Net Income | $23M |
Field | Value (USD) |
---|---|
Total Assets | $5.9M |
Total Current Assets | $5.8M |
Cash And Cash Equivalents At Carrying Value | $5.6M |
Cash And Short Term Investments | $5.6M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $164K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $151K |
Other Non Current Assets | - |
Total Liabilities | $19M |
Total Current Liabilities | $1.3M |
Current Accounts Payable | $992K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $31K |
Total Non Current Liabilities | $18M |
Capital Lease Obligations | $59K |
Long Term Debt | $203K |
Current Long Term Debt | $5K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $267K |
Other Current Liabilities | $252K |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$13M |
Treasury Stock | - |
Retained Earnings | -$132M |
Common Stock | $1K |
Common Stock Shares Outstanding | $372K |
Field | Value (USD) |
---|---|
Operating Cashflow | -$12M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $36K |
Capital Expenditures | $104K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$104K |
Cashflow From Financing | $14M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$23M |
Field | Value (USD) |
---|---|
Gross Profit | -$36K |
Total Revenue | $0 |
Cost Of Revenue | $36K |
Costof Goods And Services Sold | $36K |
Operating Income | -$15M |
Selling General And Administrative | $4.7M |
Research And Development | $9.5M |
Operating Expenses | $15M |
Investment Income Net | - |
Net Interest Income | -$566K |
Interest Income | $62K |
Interest Expense | $583K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $36K |
Income Before Tax | $23M |
Income Tax Expense | $23M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$23M |
Comprehensive Income Net Of Tax | - |
Ebit | -$22M |
Ebitda | -$22M |
Net Income | $23M |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
GlucoTrack, Inc., a medical device company, designs, develops and markets noninvasive glucose monitoring devices for people with diabetes and prediabetes in Europe and Asia Pacific. The company is headquartered in Or Yehuda, Israel.